tirzepatide news september 27 2025 US pharmaceutical giant Eli Lilly's weight loss drug Mounjaro (tirzepatide) records Rs 80 crore in revenue in September, making it the second-most sold drug by value in India. The top-selling drug for Patients struggle to get weight

People with diabetes, kidney disease, gallbladder or pancreatic disorders, cardiovascular disease, hormone-sensitive conditions or a history of certain cancers should exercise particular caution

Semaglutide is a medication originally developed to treat Type 2 diabetes

Tampoco significa que cada va contribuya en la misma proporcin a un resultado integrado

You dont have to keep feeling this way

Because of this, the exact time of injection matters less compared to staying consistent with dosing

It's hard to believe, but demand for GLP-1 weight loss drugs is almost certain to explode in 2026 even more so than this year, as the first pill versions hit the market and prices start coming down.